Connect with us

Health

ChikV is back!  The Americas see sharp increase and nearly 100 deaths

Published

on

By Rashaed Esson with Deandrea Hamilton

Editorial Staff

 

 

March 23, 2023 – The region is once again facing off with a public health risk and while not new,  the return, prevalence and lethal impact of the virus is wreaking new and heartbreaking havoc; it has also caused the Pan American Health Organization to issue warnings to Member countries urging them to prepare and reinforce their responses to Chikunguna; transmitted by mosquito and responsible for nearly 100 deaths last year.

According to PAHO, the Americas saw an increase in deaths and cases from ChikV in 2022. In fact, PAHO charted 273,685 cases and 87 deaths in 2022; 14 countries and territories in the Americans were reporting.

“This figure is higher than that observed in the same period of 2021 (137,025 cases, including 12 deaths),” according to PAHO/WHO.

In addition, the occurrence of the diseases has gone beyond the historical areas of transmission reported since 2014, which leaked into the first few weeks of 2023.

Paraguay and Brazil were identified in the March 8 report.  The pair of South/Central American countries carry the highest incidence rates of 1,128 cases per 100,000 population.  For Paraguay and 14.2 cases per 100,000 population and for Brazil or 115,539 cases and 33 deaths were reported in the first epidemiological week (EW) of 2023.

For Paraguay, between December and February, a total of 34,659 cases were categorised as probable and confirmed, including 2,910 hospitalizations and 34 deaths.

It is unimaginable that after pushing down the instance and detrimental impacts of ChikV that any nation would count 34 people dead as a result of the mosquito borne virus.  While control of the virus is relatively good, progress on life-saving, preventative medical intervention is stagnant.

“While there are several vaccines currently in different stages of development (as of Dec 2022) they are yet to be licensed. There is no commercial vaccine available to protect against chikungunya virus infection,” informs the World Health Organization.

Meanwhile, the virus spread chiefly by the Aedes aegypti or Aedes albopictus mosquitoes is giving no indication of slowing down in the two nations cited as concerning by PAHO.

“Of total of cases reported (in Paraguay) during this period, 93% of cases (32,258/34,659) and 97% (33/34) of deaths were reported between EW 1 and 8 in 2023,” according to PAHO/WHO.

For Brazil, in 2023, between January and February, there were 35,566 probable and confirmed cases; a 109.6 percent relative increase compared to the same period in 2022. One death is confirmed as due to ChikV; 13 others are still under investigation.

Health

AstraZeneca withdraws COVID vaccines after millions took their jabs

Published

on

Rashaed Esson

Staff Writer 

 

May 8th, 2024 – After millions of people took the AstraZeneca vaccine as their choice of vaccination during the COVID-19 pandemic, the organization announced on March 5, that  it is withdrawing its vaccines from the market worldwide, effective as of May 7 as it was reported to cause side effects.

It is said 170 countries received doses of AstraZeneca; it was expected 35.3 million doses would be shared with 36 Caribbean and Latin American countries through the COVAX program, according to PAHO.

First reported by the Telegraph, the side effects are identified as blood clots and low blood platelet counts.  In fact, the medical issues have reportedly been linked to 81 confirmed deaths in the UK alone.  Many others are suffering some other medical injury due to the vaccine popularized as an answer to the then new virus.

AstraZeneca is also being sued by more than 45 affected people.

The vaccine, known as Vaxzevria, the Telegraph informs, can no longer be used in the European Union and it will be the same for other countries and the UK in the coming months.  Over 17 million doses made it into EU countries.

Reports say AstraZeneca made the revelations of the side effects in court documents, adding that the withdrawal of their vaccine is also due to a decrease in demand.

Photo Caption: Public Health Nurse, Patricia Coates (left), administers Daniel Adams’ first dose of the AstraZeneca coronavirus (COVID-19) vaccine, during the second COVID-19 Vaccination Blitz at the National Arena in St. Andrew, on Saturday (April 3).

JIS photo from 2021. 

Continue Reading

Health

Case of Malaria Identified in TCI

Published

on

Providenciales, Turks and Caicos Islands – Wednesday, 8th May 2024: A case of malaria has been identified in the Turks and Caicos Islands. The individual is presently stable and receiving treatment. The Public Health team is currently conducting further investigations, however, initial findings indicate the case may be imported. The Ministry of Health and Human Services is working closely with its stakeholders to respond to this finding.

Malaria is an acute febrile illness caused by Plasmodium parasites, which are spread to people through the bites of infected female Anopheles mosquitoes. Malaria is not contagious and cannot spread from one person to another. It is preventable and curable. However, without prompt diagnosis and effective treatment, a case of uncomplicated malaria can progress to a severe form of the disease, which is often fatal without treatment.

There are five species of Plasmodium parasites that cause malaria in humans and 2 of these species – Plasmodium falciparum and Plasmodium vivax – pose the greatest threat. Not all Anopheles mosquitoes have malaria, but if they bite a person with malaria, they can become infectious.

Symptoms

Malaria symptoms range from very mild illness to severe disease and even death. The first symptoms of malaria usually begin within 10–15 days after the bite from an infected mosquito. Early symptoms can include:

  • Fever and flu-like illness
  • Chills
  • Headache, muscle aches, and tiredness
  • Nausea, vomiting, and diarrhea may also occur

If not treated quickly, the infection can become severe.  If Plasmodium falciparum malaria is not treated within 24 hours, the infection can progress to severe illness and death.

Severe symptoms can include:

  • kidney failure
  • seizures
  • mental confusion
  • coma

See a healthcare provider as soon as possible if:

  • you are experiencing any of the symptoms of malaria, and
  • you have traveled in the last year to or from an area where malaria occurs

Only a healthcare provider can diagnose malaria. A lab test via microscopy and/or rapid diagnostic tests (RDTs) will confirm malaria using a small sample of your blood.

Prescription drugs can treat and cure malaria.

Prevention

Persons traveling to countries where malaria is endemic should take precautions to prevent infection including taking chemoprophylaxis (use of medications to prevent infection).

For additional information, please visit the Ministry of Health and Human Services Facebook page onhttps://www.facebook.com/tciministryofhealth/.

 

Continue Reading

Health

Successful Community Kidney Screening Events Hosted by InterHealth Canada – TCI Hospital and Ministry of Health and Human Services in Grand Turk and Salt Cay

Published

on

(Providenciales, Turks and Caicos Islands – Friday, April 19th, 2024): – InterHealth Canada Turks and Caicos Islands Hospital, in partnership with the Ministry of Health and Human Services, is delighted to announce the successful completion of the Community Kidney Screening Events held in Grand Turk and Salt Cay. These events marked a significant milestone in promoting kidney health awareness and early detection.

On April 12, 2024, on Grand Turk (Dillon Hall) and April 13, 2024, on Salt Cay (Ministry of Health Clinic), participants had the opportunity to receive immediate screening results and personalized guidance from dedicated healthcare professionals. The collaborative effort between InterHealth Canada-Turks and Caicos Islands Hospital and the Ministry of Health and Human Services empowered individuals to prioritize their kidney health and take proactive steps towards well-being.

Reflecting on the event’s success, Dr Denise Braithwaite-Tennant, CEO of InterHealth Canada Turks and Caicos Islands Hospital, shared, “We are happy to see the positive impact of the Community Kidney Screening Events in Grand Turk and Salt Cay. By providing accessible screenings and expert guidance by our clinical teams, including our nephrologist and internist, we equip individuals with the knowledge to make informed decisions about their kidney health.”

Similarly, Dr Camelia Clarke, Director of the Health Promotion and Advocacy Unit of the Ministry of Health and Human Services, expressed her satisfaction with the outcomes, stating, “These events have showcased the importance of early detection and preventive care in maintaining optimal kidney health.”

The support of sponsors, including the TCI Boating Club, Air and Sea Agency, The Olympic Group Limited, Flow and Digicel, played a crucial role in the success of the Community Kidney Screening Events.

InterHealth-Canada Turks and Caicos Islands Hospital and the Ministry of Health and Human Services are excited to announce that a series of Kidney Community Screenings with dates for Providenciales, North and Middle Caicos, and South Caicos will be revealed soon, further extending the impact of this important initiative.

The Community Kidney Screening Events in Grand Turk and Salt Cay have set a solid foundation for ongoing efforts to prioritize kidney health and well-being within the community. Together, we are taking proactive steps towards building a healthier future for all.

Continue Reading

FIND US ON FACEBOOK

TRENDING